J. Scott Wolchko - 21 Apr 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
President and CEO, Director
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
21 Apr 2022
Net transactions value
-$1,395,792
Form type
4
Filing time
25 Apr 2022, 16:11:06 UTC
Previous filing
27 Jan 2022
Next filing
25 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $81,000 +30,000 +7% $2.70 461,546 21 Apr 2022 Direct F1
transaction FATE Common Stock Sale $785,258 -22,715 -4.9% $34.57* 438,831 21 Apr 2022 Direct F1, F2
transaction FATE Common Stock Sale $145,135 -4,062 -0.93% $35.73* 434,769 21 Apr 2022 Direct F1, F3
transaction FATE Common Stock Sale $81,474 -2,220 -0.51% $36.70* 432,549 21 Apr 2022 Direct F1, F4
transaction FATE Common Stock Sale $38,014 -1,003 -0.23% $37.90* 431,546 21 Apr 2022 Direct F1, F5
transaction FATE Common Stock Options Exercise $27,000 +10,000 +2.3% $2.70 441,546 22 Apr 2022 Direct F1
transaction FATE Common Stock Sale $316,455 -9,162 -2.1% $34.54* 432,384 22 Apr 2022 Direct F1, F6
transaction FATE Common Stock Sale $29,456 -838 -0.19% $35.15* 431,546 22 Apr 2022 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $81,000 -30,000 -39% $2.70 46,246 21 Apr 2022 Common Stock 30,000 $2.70 Direct F1, F8
transaction FATE Stock Option (Right to Buy) Options Exercise $27,000 -10,000 -22% $2.70 36,246 22 Apr 2022 Common Stock 10,000 $2.70 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.
F2 Represents the weighted average sale price of the shares sold from $34.22 to $35.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7.
F3 Represents the weighted average sale price of the shares sold from $35.29 to $36.25 per share.
F4 Represents the weighted average sale price of the shares sold from $36.29 to $37.08 per share.
F5 Represents the weighted average sale price of the shares sold from $37.70 to $38.38 per share.
F6 Represents the weighted average sale price of the shares sold from $34.04 to $35.03 per share.
F7 Represents the weighted average sale price of the shares sold from $35.04 to $35.29 per share.
F8 This option is fully vested.